{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/ic402015q.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>Doping a functional ligand into a\nknown crystalline system built from ligands of similar shape and length\nprovides a powerful strategy to construct functional metal\u2013organic\nframeworks (MOFs) with desired functionality and structural topology.\nThis mix-and-match approach mimics the widely applied metal ion doping\n(or solid solution formation) in traditional inorganic materials,\nsuch as metal oxides, wherein maintaining charge balance of the doped\nlattice and ensuring size match between doped metal ions and the parent\nlattice are key to successful doping. In this work, we prepared three\nsterically demanding dicarboxylate ligands based on Ir/Ru-phosphors\nwith similar structures and variable charges (\u22122 to 0), [Ir(ppy)<sub>3</sub>]-dicarboxylate (<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>,\nppy is 2-phenylpyridine), [Ir(bpy)(ppy)<sub>2</sub>]<sup>+</sup>-dicarboxylate\n(<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>, bpy is 2,2\u2032-bipyridine),\nand Ru(bpy)<sub>3</sub>]<sup>2+</sup>-dicarboxylate (<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>), and successfully doped them into the\nknown IRMOF-9/-10 structures by taking advantage of matching length\nbetween 4,4\u2032-biphenyl dicarboxylate (BPDC) and <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\u2013<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>. We systematically investigated the effects of size and charge\nof the doping ligand on the MOF structures and the ligand doping levels\nin these MOFs. <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> carries a \u22122\ncharge to satisfy the charge requirement of the parent Zn<sub>4</sub>O(BPDC)<sub>3</sub> framework and can be mixed into the IRMOF-9/-10\nstructure in the whole range of H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>/H<sub>2</sub>BPDC ratios from 0 to 1. The steric bulk\nof <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> induces a phase transition\nfrom the interpenetrated IRMOF-9 structure to the non-interpenetrated\nIRMOF-10 counterpart. <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> do not match the dinegative charge\nof BPDC in order to maintain the charge balance for a neutral IRMOF-9/-10\nframework and can only be doped into the IRMOF-9 structure to a certain\ndegree. <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> form a charge-balanced new phase with a\nneutral framework structure at higher doping levels (&gt;8% For <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and &gt;6% For <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>). This systematic investigation reveals the\ninfluences of steric demand and charge balance on ligand doping in\nMOFs, a phenomenon that has been well-established in metal ion doping\nin traditional inorganic materials.</p>", "clean_text": "Doping a functional ligand into a known crystalline system built from ligands of similar shape and length provides a powerful strategy to construct functional metal-organic frameworks (MOFs) with desired functionality and structural topology. This mix-and-match approach mimics the widely applied metal ion doping (or solid solution formation) in traditional inorganic materials, such as metal oxides, wherein maintaining charge balance of the doped lattice and ensuring size match between doped metal ions and the parent lattice are key to successful doping. In this work, we prepared three sterically demanding dicarboxylate ligands based on Ir/Ru-phosphors with similar structures and variable charges (-2 to 0), [Ir(ppy)3]-dicarboxylate (L  1 , ppy is 2-phenylpyridine), [Ir(bpy)(ppy)2]+-dicarboxylate (L  2 , bpy is 2,2'-bipyridine), and Ru(bpy)3]2+-dicarboxylate (L  3 ), and successfully doped them into the known IRMOF-9/-10 structures by taking advantage of matching length between 4,4'-biphenyl dicarboxylate (BPDC) and L  1 -L  3 . We systematically investigated the effects of size and charge of the doping ligand on the MOF structures and the ligand doping levels in these MOFs. L  1  carries a -2 charge to satisfy the charge requirement of the parent Zn4O(BPDC)3 framework and can be mixed into the IRMOF-9/-10 structure in the whole range of H2 L  1 /H2BPDC ratios from 0 to 1. The steric bulk of L  1  induces a phase transition from the interpenetrated IRMOF-9 structure to the non-interpenetrated IRMOF-10 counterpart. L  2  and L  3  do not match the dinegative charge of BPDC in order to maintain the charge balance for a neutral IRMOF-9/-10 framework and can only be doped into the IRMOF-9 structure to a certain degree. L  2  and L  3  form a charge-balanced new phase with a neutral framework structure at higher doping levels (>8% For L  2  and >6% For L  3 ). This systematic investigation reveals the influences of steric demand and charge balance on ligand doping in MOFs, a phenomenon that has been well-established in metal ion doping in traditional inorganic materials.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>Three sterically demanding\nIr/Ru phosphor-based dicarboxylate ligands of varying charges were\nsystematically doped into the known IRMOF-9/-10 structures. The doped\nsystems exhibit a strong tendency of adopting neutral framework structures,\nwith the maximum ligand doping levels depending on the charge of the\nligands. Our findings indicate important roles of steric demand and\ncharge balance on ligand doping in metal\u2212organic frameworks.</p>", "clean_text": "Three sterically demanding Ir/Ru phosphor-based dicarboxylate ligands of varying charges were systematically doped into the known IRMOF-9/-10 structures. The doped systems exhibit a strong tendency of adopting neutral framework structures, with the maximum ligand doping levels depending on the charge of the ligands. Our findings indicate important roles of steric demand and charge balance on ligand doping in metal-organic frameworks.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Metal\u2013organic\nframeworks (MOFs) have recently emerged as a new class of functional\nmaterials whose properties can be readily tuned at the molecular level. Rational design and incorporation of building blocks with various\nfunctionalities into MOF structures permit the synthesis of a variety\nof MOFs for applications in many areas, including gas storage, chemical sensing, catalysis, biomedical imaging, and drug delivery.\n</p>", "clean_text": "Introduction\n\nMetal-organic frameworks (MOFs) have recently emerged as a new class of functional materials whose properties can be readily tuned at the molecular level. Rational design and incorporation of building blocks with various functionalities into MOF structures permit the synthesis of a variety of MOFs for applications in many areas, including gas storage, chemical sensing, catalysis, biomedical imaging, and drug delivery. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>The art of systematic\nstructure engineering and property tuning is best illustrated by isoreticular\nMOFs (IRMOFs) that are constructed by linking metal-coordinated secondary\nbuilding units (SBUs) with bridging ligands of varied length or functional\ngroups. IRMOFs adopt the same framework topology but possess tunable pore\nsizes and properties. However, it is not always possible to assemble\na functional ligand into a predesigned framework structure, particularly\nwhen substantial steric demands are imposed by the functional entities.\nPostsynthetic modifications (PSM) of interior MOF channels have been\nutilized to successfully introduce functional groups that cannot be\ndirectly incorporated. However, PSM tends to reduce the open channel sizes,\nthus adversely affecting material properties in many cases. Here we\npropose an attractive alternative to constructing materials possessing\ndesired functionality and crystal structures by doping a fraction\nof functional ligand into a known crystalline phase built from a much\nsimpler ligand of identical length. This mix-and-match approach mimics the widely adopted metal ion\ndoping strategy in traditional inorganic materials (e.g., metal oxides)\nto not only allow the incorporation of sterically demanding functional\nligands into the parent framework but also retain the porosity of\nthe framework for various applications. The ligand doping strategy\nreported in this paper is distinct from the widely reported metal\nion doping into a host MOF structure.\n</p>", "clean_text": "The art of systematic structure engineering and property tuning is best illustrated by isoreticular MOFs (IRMOFs) that are constructed by linking metal-coordinated secondary building units (SBUs) with bridging ligands of varied length or functional groups. IRMOFs adopt the same framework topology but possess tunable pore sizes and properties. However, it is not always possible to assemble a functional ligand into a predesigned framework structure, particularly when substantial steric demands are imposed by the functional entities. Postsynthetic modifications (PSM) of interior MOF channels have been utilized to successfully introduce functional groups that cannot be directly incorporated. However, PSM tends to reduce the open channel sizes, thus adversely affecting material properties in many cases. Here we propose an attractive alternative to constructing materials possessing desired functionality and crystal structures by doping a fraction of functional ligand into a known crystalline phase built from a much simpler ligand of identical length. This mix-and-match approach mimics the widely adopted metal ion doping strategy in traditional inorganic materials (e.g., metal oxides) to not only allow the incorporation of sterically demanding functional ligands into the parent framework but also retain the porosity of the framework for various applications. The ligand doping strategy reported in this paper is distinct from the widely reported metal ion doping into a host MOF structure. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>In conventional doped metal oxides (or solid\nsolutions), the two most significant parameters dictating the degree\nof doping are (a) the size match between doped metal ions and the\nparent lattice and (b) the maintenance of charge balance of the doped\nlattice. In our proposed mix-and-match strategy for\nMOF synthesis, it is interesting to test if the size and charge of\nthe doping ligand are also determining factors for the doping level\nin a certain structure. In this work, we prepared three sterically\ndemanding dicarboxylate ligands based on Ir/Ru-phosphors with similar\nstructures and variable charges (\u22122 to 0), [Ir(ppy)<sub>3</sub>]-dicarboxylate (<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>, ppy is\n2-phenylpyridine), [Ir(bpy)(ppy)<sub>2</sub>]<sup>+</sup>-dicarboxylate\n(<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>, bpy is 2,2\u2032-bipyridine),\nand Ru(bpy)<sub>3</sub>]<sup>2+</sup>-dicarboxylate (<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>), and successfully doped them into known\nIRMOF-9/-10 structures, in the hope of systematically investigating\nthe aforementioned questions in MOF doping.</p>", "clean_text": "In conventional doped metal oxides (or solid solutions), the two most significant parameters dictating the degree of doping are (a) the size match between doped metal ions and the parent lattice and (b) the maintenance of charge balance of the doped lattice. In our proposed mix-and-match strategy for MOF synthesis, it is interesting to test if the size and charge of the doping ligand are also determining factors for the doping level in a certain structure. In this work, we prepared three sterically demanding dicarboxylate ligands based on Ir/Ru-phosphors with similar structures and variable charges (-2 to 0), [Ir(ppy)3]-dicarboxylate (L  1 , ppy is 2-phenylpyridine), [Ir(bpy)(ppy)2]+-dicarboxylate (L  2 , bpy is 2,2'-bipyridine), and Ru(bpy)3]2+-dicarboxylate (L  3 ), and successfully doped them into known IRMOF-9/-10 structures, in the hope of systematically investigating the aforementioned questions in MOF doping.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>The Ir-based cyclometalated\ncomplexes [Ir(ppy)<sub>3</sub>] and [Ir(bpy)(ppy)<sub>2</sub>]<sup>+</sup> and the Ru complex [Ru(bpy)<sub>3</sub>]<sup>2+</sup> are\nhighly efficient phosphors with long-lived <sup>3</sup>MLCT excited\nstates. Extensive research efforts have been devoted to developing\nlight-emitting devices based on these molecules. The <sup>3</sup>MLCT phosphorescence can also be quenched through energy transfer\nto molecules with a triplet ground state such as oxygen or via a redox process between the <sup>3</sup>MLCT state and a quencher. These phosphorescent\nIr- and Ru-based molecules are thus suitable for applications in chemical\nsensing through energy transfer and in\nphotocatalysis via redox quenching.\n</p>", "clean_text": "The Ir-based cyclometalated complexes [Ir(ppy)3] and [Ir(bpy)(ppy)2]+ and the Ru complex [Ru(bpy)3]2+ are highly efficient phosphors with long-lived 3MLCT excited states. Extensive research efforts have been devoted to developing light-emitting devices based on these molecules. The 3MLCT phosphorescence can also be quenched through energy transfer to molecules with a triplet ground state such as oxygen or via a redox process between the 3MLCT state and a quencher. These phosphorescent Ir- and Ru-based molecules are thus suitable for applications in chemical sensing through energy transfer and in photocatalysis via redox quenching. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<p>IRMOF-9/-10 structures\nwere chosen to host the Ir/Ru phosphor ligands. IRMOF-9/-10 are a\npair of catenation isomers constructed from the biphenyldicarboxylic\nacid (BPDC) ligand and [Zn<sub>4</sub>(\u03bc<sub>4</sub>-O)(O<sub>2</sub>CR)<sub>6</sub>] SBUs, forming three-dimensional (3D) structures\nof the primitive cubic network (pcu) topology. IRMOF-9 has a 2-fold\ninterpenetrated structure, while IRMOF-10 is the non-interpenetrated\ncounterpart. Ligands <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\u2013<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> possess matching length to BPDC\nto allow their doping into IRMOF-9/-10 structures. As <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> carries a \u22122 charge to satisfy the\ncharge requirement of the parent Zn<sub>4</sub>O(BPDC)<sub>3</sub> framework, it can be mixed into the IRMOF-9/-10 structures in the\nwhole range of H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>/H<sub>2</sub>BPDC ratios from 0 to 1. With increasing doping levels\nof <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>, the crystals change from\nthe interpenetrated IRMOF-9 structure to the non-interpenetrated IRMOF-10\nstructure due to the steric demand of the <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand. The <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands, on the other\nhand, can only be doped into IRMOF-9/-10 structures to a certain degree\nbefore a charge-balanced new phase with neutral framework appears\nat higher doping levels. Our work illustrates a delicate balance between\nsteric demand and charge balance for ligand doping in MOFs.</p>", "clean_text": "IRMOF-9/-10 structures were chosen to host the Ir/Ru phosphor ligands. IRMOF-9/-10 are a pair of catenation isomers constructed from the biphenyldicarboxylic acid (BPDC) ligand and [Zn4(\u03bc4-O)(O2CR)6] SBUs, forming three-dimensional (3D) structures of the primitive cubic network (pcu) topology. IRMOF-9 has a 2-fold interpenetrated structure, while IRMOF-10 is the non-interpenetrated counterpart. Ligands L  1 -L  3  possess matching length to BPDC to allow their doping into IRMOF-9/-10 structures. As L  1  carries a -2 charge to satisfy the charge requirement of the parent Zn4O(BPDC)3 framework, it can be mixed into the IRMOF-9/-10 structures in the whole range of H2 L  1 /H2BPDC ratios from 0 to 1. With increasing doping levels of L  1 , the crystals change from the interpenetrated IRMOF-9 structure to the non-interpenetrated IRMOF-10 structure due to the steric demand of the L  1  ligand. The L  2  and L  3  ligands, on the other hand, can only be doped into IRMOF-9/-10 structures to a certain degree before a charge-balanced new phase with neutral framework appears at higher doping levels. Our work illustrates a delicate balance between steric demand and charge balance for ligand doping in MOFs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<title>Experimental Section</title><title>General Information</title><p>All starting materials were purchased from Aldrich and Fisher, unless\notherwise noted, and used without further purification. <sup>1</sup>H NMR spectra were recorded on a Bruker NMR 400 DRX spectrometer\nat 400 MHz and referenced to the proton resonance resulting from incomplete\ndeuteration of deuterated chloroform (\u03b4 7.26). <sup>13</sup>C{<sup>1</sup>H} NMR spectra were recorded at 100 MHz, and all of\nthe chemical shifts are reported downfield in ppm relative to the\ncarbon resonance of chloroform-<italic toggle=\"yes\">d</italic>\n<sub>1</sub> (\u03b4\n77.0). Mass spectrometric analyses were conducted using positive-ion\nelectrospray ionization on a Bruker BioTOF mass spectrometer. Single\ncrystal and powder X-ray diffraction analyses were carried out on\na Bruker SMART APEX II diffractometer system equipped with Cu-target\nX-ray tube and operated at 1600 W. For single crystal diffraction,\nthe frames were integrated with Bruker SAINT built into the APEX II\nsoftware package using a narrow-frame integration algorithm, which\nalso corrects for the Lorentz and polarization effects. Absorption\ncorrections were applied using SADABS for all of the crystals. The\nPXRD patterns were processed with the APEX II package using PILOT\nplug-in. UV\u2013vis absorption spectra were obtained using a Shimadzu\nUV-2401 PC UV\u2013vis Recording spectrophotometer. Thermogravimetric\nanalysis (TGA) was performed using a Shimadzu TGA-50 equipped with\na platinum pan, and all samples were heated at a rate of 5 \u00b0C/min\nunder air. Nitrogen adsorption experiments were performed with a Quantachrome\nAutosorb-1C.</p>", "clean_text": "Experimental Section\n\nGeneral Information\n\nAll starting materials were purchased from Aldrich and Fisher, unless otherwise noted, and used without further purification. 1H NMR spectra were recorded on a Bruker NMR 400 DRX spectrometer at 400 MHz and referenced to the proton resonance resulting from incomplete deuteration of deuterated chloroform (\u03b4 7.26). 13C{1H} NMR spectra were recorded at 100 MHz, and all of the chemical shifts are reported downfield in ppm relative to the carbon resonance of chloroform-d 1 (\u03b4 77.0). Mass spectrometric analyses were conducted using positive-ion electrospray ionization on a Bruker BioTOF mass spectrometer. Single crystal and powder X-ray diffraction analyses were carried out on a Bruker SMART APEX II diffractometer system equipped with Cu-target X-ray tube and operated at 1600 W. For single crystal diffraction, the frames were integrated with Bruker SAINT built into the APEX II software package using a narrow-frame integration algorithm, which also corrects for the Lorentz and polarization effects. Absorption corrections were applied using SADABS for all of the crystals. The PXRD patterns were processed with the APEX II package using PILOT plug-in. UV-vis absorption spectra were obtained using a Shimadzu UV-2401 PC UV-vis Recording spectrophotometer. Thermogravimetric analysis (TGA) was performed using a Shimadzu TGA-50 equipped with a platinum pan, and all samples were heated at a rate of 5 \u00b0C/min under air. Nitrogen adsorption experiments were performed with a Quantachrome Autosorb-1C.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "text", "classification": "error", "content": "<title>General Synthesis and Characterization of <bold>L</bold>/BPDC Mixed Zn-MOF Series</title><p>Mixtures of H<sub>2</sub>\n<bold>L</bold> and H<sub>2</sub>BPDC with varying molar ratios were\nreacted with Zn(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O in <italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>\u2032-dimethylformamide (DMF) under\nsolvothermal conditions. The molar ratio of Zn(NO<sub>3</sub>)<sub>2</sub>: (H<sub>2</sub>\n<bold>L</bold> + H<sub>2</sub>bpdc): DMF was\n0.5\u20133: 1: 2000. The resulting mixtures were placed in an oven\nat 100 \u00b0C for 1\u20132 days. Yellow-red crystals with thin\nplate or feather-like morphologies (depending on resulting phases)\nwere obtained after filtration. Phases of the obtained MOFs were determined\nby PXRD. Phases of the interpenetrated IRMOF-9 and the non-interpenetrated\nIRMOF-10 can be differentiated by examining the crystals under polarized\nlight. IRMOF-9, crystallizing in orthorhombic crystal system, exhibited\nanisotropic birefringent behavior under polarized light, while IRMOF-10,\ncrystallizing in cubic crystal system, was optically isotropic. Thermogravimetric\nanalysis (TGA) measuring the solvent weight loss was used to support\nthe above identification of interpenetrated vs non-interpenetrated\nphases. The Ir/Ru-complex (<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> to <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>) contents in all of the\nMOFs were determined by dissolving a known amount of MOFs in 3 mL\nof a basic water/ethanol mixture and taking UV\u2013vis measurements\nof the solution at 375.5 nm. The <bold>L</bold> contents per mass\ncould be determined from standard curves, and the molar doping levels\n[mol <bold>L</bold>/(mol bpdc + mol <bold>L</bold>)] were then calculated,\nbased on framework formulas of different phases. Whenever mixed phases\nwere encountered, estimations based on an average formula were adopted.\nFramework formulas of the stochiometric phases <bold>MOF-1</bold> to <bold>MOF-3</bold> were deduced from X-ray crystal structures and the doping\nlevel was determined from UV\u2013vis measurements, while the solvent\ncontents were established from a combination of <sup>1</sup>H NMR\nand TGA studies.</p>", "clean_text": "General Synthesis and Characterization of L/BPDC Mixed Zn-MOF Series\n\nMixtures of H2 L and H2BPDC with varying molar ratios were reacted with Zn(NO3)2\u22c56H2O in N,N'-dimethylformamide (DMF) under solvothermal conditions. The molar ratio of Zn(NO3)2: (H2 L + H2bpdc): DMF was 0.5-3: 1: 2000. The resulting mixtures were placed in an oven at 100 \u00b0C for 1-2 days. Yellow-red crystals with thin plate or feather-like morphologies (depending on resulting phases) were obtained after filtration. Phases of the obtained MOFs were determined by PXRD. Phases of the interpenetrated IRMOF-9 and the non-interpenetrated IRMOF-10 can be differentiated by examining the crystals under polarized light. IRMOF-9, crystallizing in orthorhombic crystal system, exhibited anisotropic birefringent behavior under polarized light, while IRMOF-10, crystallizing in cubic crystal system, was optically isotropic. Thermogravimetric analysis (TGA) measuring the solvent weight loss was used to support the above identification of interpenetrated vs non-interpenetrated phases. The Ir/Ru-complex (L  1  to L  3 ) contents in all of the MOFs were determined by dissolving a known amount of MOFs in 3 mL of a basic water/ethanol mixture and taking UV-vis measurements of the solution at 375.5 nm. The L contents per mass could be determined from standard curves, and the molar doping levels [mol L/(mol bpdc + mol L)] were then calculated, based on framework formulas of different phases. Whenever mixed phases were encountered, estimations based on an average formula were adopted. Framework formulas of the stochiometric phases MOF-1 to MOF-3 were deduced from X-ray crystal structures and the doping level was determined from UV-vis measurements, while the solvent contents were established from a combination of 1H NMR and TGA studies.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"ic-2013-02015q_0006.tif\"></graphic>\n</fig>", "clean_text": " 1  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 11, "type": "text", "classification": ["else"], "content": "<title>Results</title><title>Ligand Synthesis</title><p>The Ir complexes H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> and H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> were\nsynthesized by reacting [Ir(ppy)<sub>2</sub>Cl<sub>2</sub>]<sub>2</sub> with methyl-6-(4-(methoxycarbonyl)\u00adphenyl)\u00adnicotinate\n[5,5\u2032-(MeO<sub>2</sub>C)<sub>2</sub>-ppy] or diethyl(2,2\u2032-bipyridine)-5,5\u2032-dicarboxylate\n[5,5\u2032-(EtO<sub>2</sub>C)<sub>2</sub>-bpy], followed by base-promoted\nhydrolysis (). The\nRu-complex H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> was\nsynthesized following the published procedure by directly reacting\ncis-[Ru(bpy)<sub>2</sub>Cl<sub>2</sub>] with 2,2\u2032-bipyridine\n5,5\u2032-dicarboxylic acid [5,5\u2032-(HO<sub>2</sub>C)<sub>2</sub>-bpy] (). Syntheses\nand characterization of these ligands were reported previously.\n</p>", "clean_text": "Results\n\nLigand Synthesis\n\nThe Ir complexes H2 L  1  and H2 L  2  were synthesized by reacting [Ir(ppy)2Cl2]2 with methyl-6-(4-(methoxycarbonyl)phenyl)nicotinate [5,5'-(MeO2C)2-ppy] or diethyl(2,2'-bipyridine)-5,5'-dicarboxylate [5,5'-(EtO2C)2-bpy], followed by base-promoted hydrolysis (). The Ru-complex H2 L  3  was synthesized following the published procedure by directly reacting cis-[Ru(bpy)2Cl2] with 2,2'-bipyridine 5,5'-dicarboxylic acid [5,5'-(HO2C)2-bpy] (). Syntheses and characterization of these ligands were reported previously. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<title>Systematic Doping Studies\nof <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-Based MOFs</title><p>We\nhypothesized that Ir/Ru phosphor-based dicarboxylate ligands <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\u2013<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> can link the octahedral [Zn<sub>4</sub>(\u03bc<sub>4</sub>-O)(O<sub>2</sub>CR)<sub>6</sub>] SBUs to form isoreticular\nMOFs (IRMOF-9 or IRMOF-10 structure) of the pcu topology. Reactions\nbetween H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> and Zn(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O in DMF afforded red single\ncrystals of [Zn<sub>4</sub>(\u03bc<sub>4</sub>-O)(<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>)<sub>3</sub>]\u00b764DMF\u00b735H<sub>2</sub>O (MOF-<bold>1</bold>). MOF-<bold>1</bold> crystallizes in the cubic <italic toggle=\"yes\">Fm</italic>3\u0305<italic toggle=\"yes\">m</italic> space group with 1/8 of <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligands and 1/24 of Zn<sub>4</sub>(\u03bc<sub>4</sub>-O) clusters which are composed of one Zn atom\nof 1/6 occupancy and one O atom of 1/24 occupancy in the asymmetric\nunit. As expected, the carboxylate groups from six adjacent <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligands coordinate to the four\nZn centers to form [Zn<sub>4</sub>(\u03bc<sub>4</sub>-O)(carboxylate)<sub>6</sub>] SBUs which link <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligands\nto form a non-interpenetrated 3D network of the IRMOF-10 structure\n(Figure a). <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligands were disordered over two positions as a result of\nthe rotation of the C\u2013C bond between the carboxylate groups\nand the aromatic rings, a common phenomenon observed when 2-connected\ndicarboxylate acids were employed as linkers. PLATON calculations\nindicated that <bold>1</bold> possesses 79% void space that is filled\nby DMF or water molecules. The disordered nature of the solvent molecules\nprecluded their precise location by X-ray crystallography. The solvent\ncontents were instead established by a combination of <sup>1</sup>H NMR studies and thermogravimetric analyses ().\n</p>", "clean_text": "Systematic Doping Studies of L  1 -Based MOFs\n\nWe hypothesized that Ir/Ru phosphor-based dicarboxylate ligands L  1 -L  3  can link the octahedral [Zn4(\u03bc4-O)(O2CR)6] SBUs to form isoreticular MOFs (IRMOF-9 or IRMOF-10 structure) of the pcu topology. Reactions between H2 L  1  and Zn(NO3)2\u22c56H2O in DMF afforded red single crystals of [Zn4(\u03bc4-O)(L  1 )3]\u22c564DMF\u22c535H2O (MOF-1). MOF-1 crystallizes in the cubic Fm3\u0305m space group with 1/8 of L  1  ligands and 1/24 of Zn4(\u03bc4-O) clusters which are composed of one Zn atom of 1/6 occupancy and one O atom of 1/24 occupancy in the asymmetric unit. As expected, the carboxylate groups from six adjacent L  1  ligands coordinate to the four Zn centers to form [Zn4(\u03bc4-O)(carboxylate)6] SBUs which link L  1  ligands to form a non-interpenetrated 3D network of the IRMOF-10 structure (Figure a). L  1  ligands were disordered over two positions as a result of the rotation of the C-C bond between the carboxylate groups and the aromatic rings, a common phenomenon observed when 2-connected dicarboxylate acids were employed as linkers. PLATON calculations indicated that 1 possesses 79% void space that is filled by DMF or water molecules. The disordered nature of the solvent molecules precluded their precise location by X-ray crystallography. The solvent contents were instead established by a combination of 1H NMR studies and thermogravimetric analyses (). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Key Crystallographic Data for MOFs <bold>1</bold>\u2013<bold>3</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">MOF-1</oasis:entry>\n<oasis:entry align=\"center\">MOF-2</oasis:entry>\n<oasis:entry align=\"center\">MOF-3</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>framework\nformula</oasis:entry>\n<oasis:entry>[Zn<sub>4</sub>O(<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>)<sub>3</sub>]</oasis:entry>\n<oasis:entry>[Zn<sub>2</sub>(BPDC)<sub>1.5</sub>(<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>)]</oasis:entry>\n<oasis:entry>[Zn<sub>2</sub>(BPDC)<sub>2</sub>(<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>)<sub>0.5</sub>]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space\ngroup</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">Fm</italic>3<italic toggle=\"yes\">\u0305m</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>222<sub>1</sub>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>222<sub>1</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cell\ndimensions (\u00c5)</oasis:entry>\n<oasis:entry>34.0 \u00d7 34.0 \u00d7 34.0</oasis:entry>\n<oasis:entry>18.4 \u00d7\n26.3 \u00d7 42.4</oasis:entry>\n<oasis:entry>18.5 \u00d7 26.9 \u00d7 41.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>interpenetration</oasis:entry>\n<oasis:entry>none</oasis:entry>\n<oasis:entry>2-fold</oasis:entry>\n<oasis:entry>2-fold</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>void\nspace % calcd by PLATON</oasis:entry>\n<oasis:entry>79</oasis:entry>\n<oasis:entry>45</oasis:entry>\n<oasis:entry>60</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>solvent content<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>64DMF\u00b735H<sub>2</sub>O</oasis:entry>\n<oasis:entry>2DMF\u00b77H<sub>2</sub>O</oasis:entry>\n<oasis:entry>9DMF\u00b78H<sub>2</sub>O</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>solvent\nweight loss (%)</oasis:entry>\n<oasis:entry>68</oasis:entry>\n<oasis:entry>19</oasis:entry>\n<oasis:entry>47</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>calculated framework density (g/cm<sup>3</sup>)</oasis:entry>\n<oasis:entry>0.843</oasis:entry>\n<oasis:entry>0.800</oasis:entry>\n<oasis:entry>0.601</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>Solvent contents were determined by a combination of <sup>1</sup>H NMR spectroscopy and TGA. See <xref rid=\"notes-1\">Supporting\nInformation</xref> for detailed analyses.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 14, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>(a) Stick/polyhedral model for <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-doped non-interpenetrated IRMOF-10 structure. (b) Stick/polyhedral\nmodel for <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-doped interpenetrated\nIRMOF-9 structure.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"ic-2013-02015q_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  (a) Stick/polyhedral model for L  1 -doped non-interpenetrated IRMOF-10 structure. (b) Stick/polyhedral model for L  1 -doped interpenetrated IRMOF-9 structure.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 15, "type": "text", "classification": "error", "content": "<p>In contrast to the formation\nof the non-interpenetrated IRMOF-10 structure from reactions between\nH<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> and Zn(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O in DMF, reactions between\nH<sub>2</sub>BPDC and Zn(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O under similar reaction conditions in DMF yielded interpenetrated\nIRMOF-9. Given the similar length of these\ntwo dicarboxylate ligands, the formation of MOF-<bold>1</bold> of\nthe non-interpenetrated IRMOF-10 structure can be attributed to the\nsteric bulk of the <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand.\nWhen a mixture of H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> and H<sub>2</sub>BPDC in varying molar ratios was reacted with Zn(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O in DMF under solvothermal\nconditions, crystalline samples were obtained from all of the reaction\nvials. On the basis of PXRD patterns (Figure a), <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> forms a solid solution\nwith BPDC to adopt IRMOF-9/-10 structures in the whole range of L<sub>1</sub>/BPDC molar ratios from 0 to 1 (Table ). Here \u201csolid solution\u201d refers to MOF crystals that\nare built from a mixture of two ligands of similar shape and length\nin the same structure. The two ligands occupy the same crystallographic\nposition statistically. It is necessary to differentiate between the\nformation of a \u201csolid solution\u201d and a mixture of two\ncrystals constructed from two different ligands. In this case, as\nthe <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand is red and the\nbpdc ligand is colorless, any crystals that are colored must contain <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand. In the experiment, even\nwith a very small amount of <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand added in the synthesis, every crystal under the microscope\nappeared to be colored (see  for a photo of sample <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-BPDC-2). The light orange color indicates that those\ncrystals cannot be 100% of <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand either. We thus believe that <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand and bpdc ligand can form solid solutions. We cannot, however, rule out the possible variations of the <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>/bpdc ratios in different crystals.\nAlthough PXRD patterns of IRMOF-9 and IRMOF-10 are very similar, these\ntwo phases can be differentiated by examining the crystals under polarized\nlight. IRMOF-9, crystallizing in the orthorhombic crystal system (space\ngroup <italic toggle=\"yes\">C</italic>222<sub>1</sub>), exhibits anisotropic birefringent\nbehavior under polarized light. On other hand, IRMOF-10 crystallizes\nin the cubic crystal system (space group <italic toggle=\"yes\">Fm</italic>3<italic toggle=\"yes\">\u0305m</italic>) and is optically isotropic. The crystals change\nfrom the interpenetrated IRMOF-9 structure to the non-interpenetrated\nIRMOF-10 structure when the doping level of <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> increases. The solvent weight losses measured by TGA\nsupported the above identification of interpenetrated vs non-interpenetrated\nphases as shown in Figure b. Going from IRMOF-9\nto IRMOF-10 structure (with a mixture of both IRMOF-9 and IRMOF-10\nphases in the intermediate range), the solvent weight loss of the\nsamples increases from 44% for the IRMOF-9 phase with 4.5% doped <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> to 68% for MOF-<bold>1</bold> with\nthe IRMOF-10 structure. The amounts of the <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand in these crystals were quantified by UV\u2013vis\nspectroscopy (Table ). The steric demand of\nthe <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand drives phase transition\nfrom interpenetrated to more open, non-interpenetrated structure,\nshowing the importance of ligand size in systematic ligand doping.</p>", "clean_text": "In contrast to the formation of the non-interpenetrated IRMOF-10 structure from reactions between H2 L  1  and Zn(NO3)2\u22c56H2O in DMF, reactions between H2BPDC and Zn(NO3)2\u22c56H2O under similar reaction conditions in DMF yielded interpenetrated IRMOF-9. Given the similar length of these two dicarboxylate ligands, the formation of MOF-1 of the non-interpenetrated IRMOF-10 structure can be attributed to the steric bulk of the L  1  ligand. When a mixture of H2 L  1  and H2BPDC in varying molar ratios was reacted with Zn(NO3)2\u22c56H2O in DMF under solvothermal conditions, crystalline samples were obtained from all of the reaction vials. On the basis of PXRD patterns (Figure a), L  1  forms a solid solution with BPDC to adopt IRMOF-9/-10 structures in the whole range of L1/BPDC molar ratios from 0 to 1 (Table ). Here \"solid solution\" refers to MOF crystals that are built from a mixture of two ligands of similar shape and length in the same structure. The two ligands occupy the same crystallographic position statistically. It is necessary to differentiate between the formation of a \"solid solution\" and a mixture of two crystals constructed from two different ligands. In this case, as the L  1  ligand is red and the bpdc ligand is colorless, any crystals that are colored must contain L  1  ligand. In the experiment, even with a very small amount of L  1  ligand added in the synthesis, every crystal under the microscope appeared to be colored (see  for a photo of sample L  1 -BPDC-2). The light orange color indicates that those crystals cannot be 100% of L  1  ligand either. We thus believe that L  1  ligand and bpdc ligand can form solid solutions. We cannot, however, rule out the possible variations of the L  1 /bpdc ratios in different crystals. Although PXRD patterns of IRMOF-9 and IRMOF-10 are very similar, these two phases can be differentiated by examining the crystals under polarized light. IRMOF-9, crystallizing in the orthorhombic crystal system (space group C2221), exhibits anisotropic birefringent behavior under polarized light. On other hand, IRMOF-10 crystallizes in the cubic crystal system (space group Fm3\u0305m) and is optically isotropic. The crystals change from the interpenetrated IRMOF-9 structure to the non-interpenetrated IRMOF-10 structure when the doping level of L  1  increases. The solvent weight losses measured by TGA supported the above identification of interpenetrated vs non-interpenetrated phases as shown in Figure b. Going from IRMOF-9 to IRMOF-10 structure (with a mixture of both IRMOF-9 and IRMOF-10 phases in the intermediate range), the solvent weight loss of the samples increases from 44% for the IRMOF-9 phase with 4.5% doped L  1  to 68% for MOF-1 with the IRMOF-10 structure. The amounts of the L  1  ligand in these crystals were quantified by UV-vis spectroscopy (Table ). The steric demand of the L  1  ligand drives phase transition from interpenetrated to more open, non-interpenetrated structure, showing the importance of ligand size in systematic ligand doping.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 16, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>(a) PXRD\npatterns for <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-doped IRMOF-9/-10\nsamples; (b) TGA of <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-doped\nIRMOF-9/-10 samples. Preparation conditions, BPDC/<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> content ratios, and the identified phases of\nall of the samples in (a) and (b) are listed in Table <xref rid=\"tbl2\"></xref>. The samples from <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-BPDC-<bold>1</bold> to <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-BPDC-<bold>5</bold> change from the IRMOF-9 structure to the IRMOF-10 structure.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"ic-2013-02015q_0003.tif\"></graphic>\n</fig>", "clean_text": " 2  (a) PXRD patterns for L  1 -doped IRMOF-9/-10 samples; (b) TGA of L  1 -doped IRMOF-9/-10 samples. Preparation conditions, BPDC/L  1  content ratios, and the identified phases of all of the samples in (a) and (b) are listed in Table . The samples from L  1 -BPDC-1 to L  1 -BPDC-5 change from the IRMOF-9 structure to the IRMOF-10 structure.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>\n<bold>L</bold> Ligand\nDoping Levels Determined by UV-Vis Spectroscopy</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">ligand and sample number</oasis:entry>\n<oasis:entry align=\"center\">molar ratio\nof Zn(NO<sub>3</sub>)<sub>2</sub>/H<sub>2</sub>\n<bold>L</bold>/H<sub>2</sub>bpdc in the<italic toggle=\"yes\"> </italic>s<italic toggle=\"yes\">y</italic>nthesis</oasis:entry>\n<oasis:entry align=\"center\">phases determined\nfrom PXRD/optical observation/TGA</oasis:entry>\n<oasis:entry align=\"center\">doping level <bold>L</bold>/(<bold>L</bold> + BPDC) (%)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>BPDC-<bold>0</bold>\n</oasis:entry>\n<oasis:entry>2/0/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>1</bold>\n</oasis:entry>\n<oasis:entry>26/1/12</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>4.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>8/1/3</oasis:entry>\n<oasis:entry>IRMOF-9 + IRMOF-10<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry>17</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>4/1/1</oasis:entry>\n<oasis:entry>IRMOF-9 + IRMOF-10</oasis:entry>\n<oasis:entry>39</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>4</bold>\n</oasis:entry>\n<oasis:entry>8/3/1</oasis:entry>\n<oasis:entry>IRMOF-9 + IRMOF-10</oasis:entry>\n<oasis:entry>61</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>5</bold>\n</oasis:entry>\n<oasis:entry>6/1/0</oasis:entry>\n<oasis:entry>IRMOF-10 (MOF-<bold>1</bold>)</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>1</bold>\n</oasis:entry>\n<oasis:entry>26/1/13</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>20/1/9</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>14/1/6</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>2</bold>\n<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>4</bold>\n</oasis:entry>\n<oasis:entry>8/1/3</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>26</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>5</bold>\n</oasis:entry>\n<oasis:entry>4/1/1</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>32</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>6</bold>\n</oasis:entry>\n<oasis:entry>8/3/1</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>40 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>7</bold>\n</oasis:entry>\n<oasis:entry>12/5/1</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>40 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>8</bold>\n</oasis:entry>\n<oasis:entry>20/9/1</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>42 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>9</bold>\n</oasis:entry>\n<oasis:entry>4/1/0</oasis:entry>\n<oasis:entry>unknown phase</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>1</bold>\n</oasis:entry>\n<oasis:entry>6.5/4.4/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>n.a.</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>6.6/3/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>3.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>5.9/1/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>4</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/12</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>3</bold>\n<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>16.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>5</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/18</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>17</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>6</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/22</oasis:entry>\n<oasis:entry>MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>21 \u00b1 3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>7</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/33</oasis:entry>\n<oasis:entry>MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>22 \u00b1 3</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>This is a mixture of IRMOF-9 and IRMOF-10 phases, based\non optical observation and TGA.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>These are mixture of IRMOF-9 and MOF-<bold>2/3</bold> phases, based\non PXRD, optical observation and TGA.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "text", "classification": ["else"], "content": "<title>Systematic Doping Studies of <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>- and <bold>L</bold>\n<sub>3</sub>-Based MOFs</title><p>Unlike\nthe dinegative <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand, mononegative <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and neutral <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands do not readily assemble into the Zn<sub>4</sub>O(<bold>L</bold>)<sub>3</sub> open framework. Reactions of\nmany kinds of zinc salts with H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> or and H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> in various mixed solvents at 80\u2013100 \u00b0C afforded\namorphous solids or powdery crystalline samples of unknown structures\n(). Nonetheless,\nwe successfully doped a small fraction of <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> into IRMOF-9\nor IRMOF-10 frameworks (built from pure BPDC ligand) by taking advantage\nof matching ligand lengths between BPDC and <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>.</sub> This mix-and-match\nstrategy can incorporate sterically demanding phosphors into the IRMOF\nstructure and retain the intrinsic porosity at the same time.</p>", "clean_text": "Systematic Doping Studies of L  2 - and L 3-Based MOFs\n\nUnlike the dinegative L  1  ligand, mononegative L  2  and neutral L  3  ligands do not readily assemble into the Zn4O(L)3 open framework. Reactions of many kinds of zinc salts with H2 L  2  or and H2 L  3  in various mixed solvents at 80-100 \u00b0C afforded amorphous solids or powdery crystalline samples of unknown structures (). Nonetheless, we successfully doped a small fraction of L  2  and L  3  into IRMOF-9 or IRMOF-10 frameworks (built from pure BPDC ligand) by taking advantage of matching ligand lengths between BPDC and L  2 /L  3. This mix-and-match strategy can incorporate sterically demanding phosphors into the IRMOF structure and retain the intrinsic porosity at the same time.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 19, "type": "text", "classification": "error", "content": "<p>Yellow-red crystals with thin plate or feather-like morphologies\nwere obtained after reacting H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>, H<sub>2</sub>BPDC, and Zn(NO<sub>3</sub>)<sub>2</sub>\u00b76H<sub>2</sub>O in DMF at 90\u2013100 \u00b0C for 1\u20132 days. PXRD\nanalyses indicated the formation of doped IRMOF frameworks with certain\nZn(NO<sub>3</sub>)<sub>2</sub>/H<sub>2</sub>\n<bold>L</bold>/H<sub>2</sub>BPDC molar ratios. Observations under polarized light and TGA analyses\nshowed that the interpenetrated IRMOF-9 phase was obtained in both <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>- and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>-doped systems. These phases show solvent weight loss ranging\nfrom 43 to 47% ().\nThe amounts of <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands in the crystals were quantified\nby UV\u2013vis spectroscopy. As listed in Table , approximately 8% <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and 6% <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> can be doped into\nthe IRMOF-9 framework.</p>", "clean_text": "Yellow-red crystals with thin plate or feather-like morphologies were obtained after reacting H2 L  2 /H2 L  3 , H2BPDC, and Zn(NO3)2\u22c56H2O in DMF at 90-100 \u00b0C for 1-2 days. PXRD analyses indicated the formation of doped IRMOF frameworks with certain Zn(NO3)2/H2 L/H2BPDC molar ratios. Observations under polarized light and TGA analyses showed that the interpenetrated IRMOF-9 phase was obtained in both L  2 - and L  3 -doped systems. These phases show solvent weight loss ranging from 43 to 47% (). The amounts of L  2  and L  3  ligands in the crystals were quantified by UV-vis spectroscopy. As listed in Table , approximately 8% L  2  and 6% L  3  can be doped into the IRMOF-9 framework.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 20, "type": "text", "classification": "error", "content": "<p>When the <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/H<sub>2</sub>BPDC or <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>/H<sub>2</sub>BPDC ratio increases, a new phase emerges. PXRD patterns\nof the new phases resulting from <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> doping are very\nsimilar (Figure ), whereas single crystal\nX-ray crystallography established the phases to be Zn<sub>2</sub>(<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>)(BPDC)<sub>1.5</sub>\u00b7(DMF)<sub>2</sub>\u00b7(H<sub>2</sub>O)<sub>7</sub> (MOF-<bold>2</bold>) and\nZn<sub>2</sub>(<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>)<sub>0.5</sub>(BPDC)<sub>2</sub>\u00b7(DMF)<sub>9</sub>\u00b7(H<sub>2</sub>O)<sub>8</sub> (MOF-<bold>3</bold>), respectively. Structure of MOF-<bold>3</bold> has been reported by us earlier. Both phases crystallize in the <italic toggle=\"yes\">C</italic>222<sub>1</sub> space group. In both structures, triblade paddle wheel [Zn<sub>2</sub>(CO<sub>2</sub>)<sub>3</sub>] SBUs were linked by ditopic BPDC or <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands to form 3D frameworks (Figure f). In the asymmetric unit, 5/2 of the dicarboxylate ligands (BPDC\nand <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>) and one Zn<sub>2</sub> triblade paddle wheel cluster\nare present. In the equatorial positions of the triblade paddle wheel,\nthree bidentate carboxylate groups of 1/2 occupancies bridge the two\nZn atoms in the SBU. These SBUs are linked by the ligand struts to\nform a two-dimensional (2D) graphene net. In the axial positions of\nthe Zn paddle wheel, a dicarboxylate ligand with two monodentate carboxylate\ngroups coordinated to the two Zn atoms, further linking the 2D nets\nto 3D frameworks of 5-connected bnn topology (Figure b). As a result of the elongated BPDC and <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands,\n2-fold interpenetrated structures were adopted by both MOFs (Figure b). There are three crystallographically distinct\ndicarboxylate ligand positions, among which two of them are in the\nequatorial positions with respect to the Zn<sub>2</sub> paddle wheel,\nand one of them is in the axial position. Except for one of the equatorial\ndicarboxylate ligand positions, which is exclusively occupied by BPDC,\nthe other two positions are mixedly occupied by BPDC and <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>. The <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands in the equatorial positions can further\ndisorder over two orientations resulting from a 180\u00b0 rotation\nalong the C\u2013C bond between the carboxylates and aromatic rings.\nBecause of weak diffraction and limited data set qualities, the degree\nof occupancies of the phosphor-based ligands in these mixedly occupied\nequatorial and axial positions cannot be reliably deduced from single\ncrystal X-ray diffraction studies. The Ir/Ru-complex contents in both\nof the MOFs were obtained by UV\u2013vis spectroscopy as shown in\nTable . The single crystal structure was then\nrefined against the X-ray data by fixing the <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>/<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> to BPDC ratio\nin the mixed ligands positions, based on the result from spectroscopic\nanalysis. In MOF-<bold>2</bold>, the determined framework formula\nwas Zn<sub>2</sub>(<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>)(BPDC)<sub>1.5</sub>, equating to 1/2 <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> vs 1/2 BPDC ligands in the mixed ligand positions; in MOF-<bold>3</bold>, the determined framework formula turned out to be Zn<sub>2</sub>(<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>)<sub>0.5</sub>(BPDC)<sub>2</sub>, equating to 1/3 L<sub>3</sub> vs 2/3 BPDC ligands in the\nmixed ligand positions. Solvent contents in the channels were determined\nby a combination of TGA and <sup>1</sup>H NMR ().\n</p>", "clean_text": "When the L  2 /H2BPDC or L  3 /H2BPDC ratio increases, a new phase emerges. PXRD patterns of the new phases resulting from L  2  and L  3  doping are very similar (Figure ), whereas single crystal X-ray crystallography established the phases to be Zn2(L  2 )(BPDC)1.5\u22c5(DMF)2\u22c5(H2O)7 (MOF-2) and Zn2(L  3 )0.5(BPDC)2\u22c5(DMF)9\u22c5(H2O)8 (MOF-3), respectively. Structure of MOF-3 has been reported by us earlier. Both phases crystallize in the C2221 space group. In both structures, triblade paddle wheel [Zn2(CO2)3] SBUs were linked by ditopic BPDC or L  2 /L  3  ligands to form 3D frameworks (Figure f). In the asymmetric unit, 5/2 of the dicarboxylate ligands (BPDC and L  2 /L  3 ) and one Zn2 triblade paddle wheel cluster are present. In the equatorial positions of the triblade paddle wheel, three bidentate carboxylate groups of 1/2 occupancies bridge the two Zn atoms in the SBU. These SBUs are linked by the ligand struts to form a two-dimensional (2D) graphene net. In the axial positions of the Zn paddle wheel, a dicarboxylate ligand with two monodentate carboxylate groups coordinated to the two Zn atoms, further linking the 2D nets to 3D frameworks of 5-connected bnn topology (Figure b). As a result of the elongated BPDC and L  2 /L  3  ligands, 2-fold interpenetrated structures were adopted by both MOFs (Figure b). There are three crystallographically distinct dicarboxylate ligand positions, among which two of them are in the equatorial positions with respect to the Zn2 paddle wheel, and one of them is in the axial position. Except for one of the equatorial dicarboxylate ligand positions, which is exclusively occupied by BPDC, the other two positions are mixedly occupied by BPDC and L  2 /L  3 . The L  2 /L  3  ligands in the equatorial positions can further disorder over two orientations resulting from a 180\u00b0 rotation along the C-C bond between the carboxylates and aromatic rings. Because of weak diffraction and limited data set qualities, the degree of occupancies of the phosphor-based ligands in these mixedly occupied equatorial and axial positions cannot be reliably deduced from single crystal X-ray diffraction studies. The Ir/Ru-complex contents in both of the MOFs were obtained by UV-vis spectroscopy as shown in Table . The single crystal structure was then refined against the X-ray data by fixing the L  2 /L  3  to BPDC ratio in the mixed ligands positions, based on the result from spectroscopic analysis. In MOF-2, the determined framework formula was Zn2(L  2 )(BPDC)1.5, equating to 1/2 L  2  vs 1/2 BPDC ligands in the mixed ligand positions; in MOF-3, the determined framework formula turned out to be Zn2(L  3 )0.5(BPDC)2, equating to 1/3 L3 vs 2/3 BPDC ligands in the mixed ligand positions. Solvent contents in the channels were determined by a combination of TGA and 1H NMR (). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(a) A photo of MOF-<bold>2</bold> crystals. (b) A simplified connectivity model showing the\ninterpentrated nets in bnn topology of MOF-<bold>2</bold>. (c) A ball-stick\nmodel showing the crystal structure of MOF-<bold>2</bold> viewed along\nthe [001] direction. (d) A ball-stick model showing the crystal structure\nof MOF-<bold>2</bold> viewed along the [010] direction. (e) A ball-stick\nmodel showing the crystal structure of MOF-<bold>2</bold> viewed along\nthe [100] direction. (f) Ball-and-stick and polyhedra presentation\nof asymmetric unit of MOF-<bold>2</bold>.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"ic-2013-02015q_0004.tif\"></graphic>\n</fig>", "clean_text": " 3  (a) A photo of MOF-2 crystals. (b) A simplified connectivity model showing the interpentrated nets in bnn topology of MOF-2. (c) A ball-stick model showing the crystal structure of MOF-2 viewed along the [001] direction. (d) A ball-stick model showing the crystal structure of MOF-2 viewed along the [010] direction. (e) A ball-stick model showing the crystal structure of MOF-2 viewed along the [100] direction. (f) Ball-and-stick and polyhedra presentation of asymmetric unit of MOF-2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Powder X-ray diffractions of (a) <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>doped BPDC-Zn system (b) <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>doped BPDC-Zn system. The preparation\ncondition/<bold>L</bold>\n<sub>\n<bold>2/3</bold>\n</sub> content/identified\nphases of all the samples in (a) and (b) were listed in Table <xref rid=\"tbl2\"></xref>.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"ic-2013-02015q_0005.tif\"></graphic>\n</fig>", "clean_text": " 4  Powder X-ray diffractions of (a) L  2  -doped BPDC-Zn system (b) L  3  -doped BPDC-Zn system. The preparation condition/L  2/3  content/identified phases of all the samples in (a) and (b) were listed in Table .   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "text", "classification": "error", "content": "<title>Assessing the Open Channels\nin Phosphor Ligand-Doped MOFs</title><p>From the crystal structures,\nall of the MOFs <bold>1</bold>\u2013<bold>3</bold> contain internal\nporosities. Nitrogen adsorption did not afford permanent porosities\nfor these MOFs (),\npresumably due to severe framework distortion upon the removal of\nsolvent molecules. Instead, we resorted to a dye uptake assay recently developed in\nour lab to assess and quantify the intrinsic porosity of the MOFs <bold>1</bold>\u2013<bold>3</bold>. This method\ndoes not require removing solvent molecules from the MOF channel in\nvacuum and thus preserves the intrinsic porosity of the MOFs. By soaking\nof the MOFs in a solution of 42 mM rhodamine 6G dye in ethanol for\n16 h, significant fractions of the rhodamine 6G were absorbed into\nthe internal channels of the MOFs, by taking advantage of the hydrophobic\nnature of the MOFs channels. The dye solution was then decanted and\nthe MOFs were quickly washed with water three times to remove dye\nmolecules adsorbed on the external surfaces of the crystals. The dye-loaded\nMOFs were then digested with disodium ethylenediaminetetraacetic acid\n(Na<sub>2</sub>EDTA) and NaOH. The amounts of released rhodamine 6G\nwere quantified by UV\u2013visible spectroscopy after acidifying\nthe solution to pH 1.1. As shown in Table , the MOFs exhibit high dye uptake capacities ranging from 1.7 wt\n% to 11.3 wt % of the framework. The amounts of uptaken dye depend\nupon the open channels and correspond to an effective dye concentration\nof 63\u2013254 mM in the MOF channels (equivalent to 1.5\u20136.0\ntimes of the original dye concentration in the EtOH solution). These\nresults unambiguously prove the accessibility of the open channels\nof the MOFs.</p>", "clean_text": "Assessing the Open Channels in Phosphor Ligand-Doped MOFs\n\nFrom the crystal structures, all of the MOFs 1-3 contain internal porosities. Nitrogen adsorption did not afford permanent porosities for these MOFs (), presumably due to severe framework distortion upon the removal of solvent molecules. Instead, we resorted to a dye uptake assay recently developed in our lab to assess and quantify the intrinsic porosity of the MOFs 1-3. This method does not require removing solvent molecules from the MOF channel in vacuum and thus preserves the intrinsic porosity of the MOFs. By soaking of the MOFs in a solution of 42 mM rhodamine 6G dye in ethanol for 16 h, significant fractions of the rhodamine 6G were absorbed into the internal channels of the MOFs, by taking advantage of the hydrophobic nature of the MOFs channels. The dye solution was then decanted and the MOFs were quickly washed with water three times to remove dye molecules adsorbed on the external surfaces of the crystals. The dye-loaded MOFs were then digested with disodium ethylenediaminetetraacetic acid (Na2EDTA) and NaOH. The amounts of released rhodamine 6G were quantified by UV-visible spectroscopy after acidifying the solution to pH 1.1. As shown in Table , the MOFs exhibit high dye uptake capacities ranging from 1.7 wt % to 11.3 wt % of the framework. The amounts of uptaken dye depend upon the open channels and correspond to an effective dye concentration of 63-254 mM in the MOF channels (equivalent to 1.5-6.0 times of the original dye concentration in the EtOH solution). These results unambiguously prove the accessibility of the open channels of the MOFs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 24, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Rhodamine 6G Dye Uptake in the Doped\nMOFs</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">sample number<xref rid=\"t3fn1\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">structure and phase</oasis:entry>\n<oasis:entry align=\"center\">doping level <bold>L</bold>/(<bold>L</bold> + BPDC) (%)</oasis:entry>\n<oasis:entry align=\"center\">void space\npercentage calculated by Platon (%) </oasis:entry>\n<oasis:entry align=\"center\">dye uptake as wt\n% of the framework (%)</oasis:entry>\n<oasis:entry align=\"center\">effective dye concentration inside\nthe MOF channels (mM)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-BPDC-5</bold>\n</oasis:entry>\n<oasis:entry>IRMOF-10 (MOF-<bold>1</bold>)</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>79</oasis:entry>\n<oasis:entry>11.3</oasis:entry>\n<oasis:entry>252</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-BPDC-1</bold>\n</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>4.5</oasis:entry>\n<oasis:entry>67</oasis:entry>\n<oasis:entry>9.8</oasis:entry>\n<oasis:entry>213</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-BPDC-6</bold>\n</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>40</oasis:entry>\n<oasis:entry>45</oasis:entry>\n<oasis:entry>1.7</oasis:entry>\n<oasis:entry>63</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-BPDC-1</bold>\n</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>6</oasis:entry>\n<oasis:entry>65</oasis:entry>\n<oasis:entry>11.1</oasis:entry>\n<oasis:entry>254</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-BPDC-6</bold>\n</oasis:entry>\n<oasis:entry>MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>20</oasis:entry>\n<oasis:entry>60</oasis:entry>\n<oasis:entry>6.1</oasis:entry>\n<oasis:entry>126</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-BPDC-3</bold>\n</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>6</oasis:entry>\n<oasis:entry>65</oasis:entry>\n<oasis:entry>10.3</oasis:entry>\n<oasis:entry>231</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t3fn1\">\n<label>*</label>\n<p>The preparation condition/<bold>L</bold> content/identified phases of all the samples in (a) and (b) were\nlisted in Table <xref rid=\"tbl2\"></xref>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "text", "classification": ["else"], "content": "<title>Discussion</title><p>The <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand can be doped into the IRMOF-9/-10 structures\n(with BPDC as the ligand) at 0\u2013100% doping levels, thanks to\nthe matching length and charge between <bold>L</bold>\n<sub>1</sub> and\nBPDC. However, the steric bulk of <bold>L</bold>\n<sub>1</sub> ligand\ninduces a phase transition from the interpenetrated IRMOF-9 structure\nto the non-interpenetrated IRMOF-10 structure, highlighting the important\nrole of the ligand size effect on ligand doping in MOFs.</p>", "clean_text": "Discussion\n\nThe L  1  ligand can be doped into the IRMOF-9/-10 structures (with BPDC as the ligand) at 0-100% doping levels, thanks to the matching length and charge between L 1 and BPDC. However, the steric bulk of L 1 ligand induces a phase transition from the interpenetrated IRMOF-9 structure to the non-interpenetrated IRMOF-10 structure, highlighting the important role of the ligand size effect on ligand doping in MOFs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 26, "type": "text", "classification": ["else"], "content": "<p>Within\nthe determined formulas for MOF-<bold>2</bold> and MOF-<bold>3</bold>, both structures obtain neutral frameworks. We propose that the\nformation of a neutral framework provides the driving force toward\nthe formation of the new phases of the bnn topology.</p>", "clean_text": "Within the determined formulas for MOF-2 and MOF-3, both structures obtain neutral frameworks. We propose that the formation of a neutral framework provides the driving force toward the formation of the new phases of the bnn topology.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<p>By doping\nthe Ir/Ru phosphor-based ligands <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\u2013<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> into the BPDC-Zn\nsystem, we have successfully obtained three series of doped MOFs as\na result of different charges of the doping ligand. The <bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub> and <bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub> ligands, carrying \u22121 and 0 charges, respectively, can only\nbe doped into the IRMOF-9 structure to certain doping levels, after\nwhich the formation of a new phase with neutral framework of the bnn\ntopology wins over the positively charged, doped IRMOF-9 structure.\nThe dinegative <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand, on\nthe other hand, forms solid solutions with H<sub>2</sub>BPDC in IRMOF-9/-10\nstructure in the whole range of H<sub>2</sub>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>/H<sub>2</sub>BPDC ratio, as a result of neutral framework\nstructures of <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>-doped IRMOF-9/-10.\nIt is also worth noting that we failed to obtain a neutral framework\nof the bnn topology with the <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub> ligand in any <bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>/BPDC ratio.\nThe charge balance in the framework thus dictates the degree of doping\nand the formation of different phases for the doped structures.</p>", "clean_text": "By doping the Ir/Ru phosphor-based ligands L  1 -L  3  into the BPDC-Zn system, we have successfully obtained three series of doped MOFs as a result of different charges of the doping ligand. The L  2  and L  3  ligands, carrying -1 and 0 charges, respectively, can only be doped into the IRMOF-9 structure to certain doping levels, after which the formation of a new phase with neutral framework of the bnn topology wins over the positively charged, doped IRMOF-9 structure. The dinegative L  1  ligand, on the other hand, forms solid solutions with H2BPDC in IRMOF-9/-10 structure in the whole range of H2 L  1 /H2BPDC ratio, as a result of neutral framework structures of L  1 -doped IRMOF-9/-10. It is also worth noting that we failed to obtain a neutral framework of the bnn topology with the L  1  ligand in any L  1 /BPDC ratio. The charge balance in the framework thus dictates the degree of doping and the formation of different phases for the doped structures.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "text", "classification": ["else"], "content": "<p>Our observations are consistent with the predominance of neutral\nframework structures of MOFs. The most commonly employed SBUs such\nas [Zn<sub>4</sub>(\u03bc<sub>4</sub>-O)\u00ad(carboxylate)<sub>6</sub>], [Cu<sub>2</sub>(carboxylate)<sub>4</sub>(sol)<sub>2</sub>], and\n[Zr<sub>6</sub>(\u03bc<sub>3</sub>-O)<sub>4</sub>(\u03bc<sub>3</sub>-OH)<sub>4</sub>\u00ad(carboxylate)<sub>12</sub>] are all charge-balanced,\nwhich form neutral frameworks if no additional charges are present\non the ligands. Even for the [M(III)<sub>3</sub>(\u03bc<sub>3</sub>-O)\u00ad(carboxylate)<sub>6</sub>(sol)<sub>3</sub>]<sup>+</sup> SBU in the MIL-101 structure\n(M = Fe<sup>3+</sup>, Cr<sup>3+</sup>), an anion such as Cl<sup>\u2013</sup> typically coordinates to the SBU to lead to a neutral framework. Although cation-templated MOF structures have\nbeen reported, their appearance frequency is much lower that than\nthat observed for zeolites or metal phosphates. Cationic frameworks with charge-balancing anions in the MOF channels\nhave been reported even less frequently. The lower tendency\nfor MOFs to adopt an anionic framework in comparison to zeolites and\nphosphates is likely a result of larger channel sizes of MOFs and\nmore hydrophobic nature of MOF channels. The larger MOF channel size\nattenuates Coulombic interactions between the cation in the cavity\nand the anionic framework as a result of larger averaged distance\nbetween the two. In a channel larger than 1 nm, the cation can be\nsolvated, which further reduces the Coulombic interaction through\na screening effect. Hydrophobic nature of MOF channels also presents\nan energetic penalty for the framework\u2013ion interactions, further\ndisfavoring the formation of charged MOF frameworks.</p>", "clean_text": "Our observations are consistent with the predominance of neutral framework structures of MOFs. The most commonly employed SBUs such as [Zn4(\u03bc4-O)(carboxylate)6], [Cu2(carboxylate)4(sol)2], and [Zr6(\u03bc3-O)4(\u03bc3-OH)4(carboxylate)12] are all charge-balanced, which form neutral frameworks if no additional charges are present on the ligands. Even for the [M(III)3(\u03bc3-O)(carboxylate)6(sol)3]+ SBU in the MIL-101 structure (M = Fe3+, Cr3+), an anion such as Cl- typically coordinates to the SBU to lead to a neutral framework. Although cation-templated MOF structures have been reported, their appearance frequency is much lower that than that observed for zeolites or metal phosphates. Cationic frameworks with charge-balancing anions in the MOF channels have been reported even less frequently. The lower tendency for MOFs to adopt an anionic framework in comparison to zeolites and phosphates is likely a result of larger channel sizes of MOFs and more hydrophobic nature of MOF channels. The larger MOF channel size attenuates Coulombic interactions between the cation in the cavity and the anionic framework as a result of larger averaged distance between the two. In a channel larger than 1 nm, the cation can be solvated, which further reduces the Coulombic interaction through a screening effect. Hydrophobic nature of MOF channels also presents an energetic penalty for the framework-ion interactions, further disfavoring the formation of charged MOF frameworks.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<title>Conclusion</title><p>We have performed systematic studies on doping three sterically\ndemanding Ir/Ru phosphor-based dicarboxylate ligands of varying charges\ninto the known IRMOF-9/-10 structures. The maximum doping levels of\nthese ligands depend on the charge of the ligands. All of the doped\nsystems exhibit a strong tendency of adopting neutral framework structures.\nThis observation is consistent with the general trend of reported\nMOF structures in the literature: neutral frameworks appear in a much\nhigher frequency than charged ones. Bulky ligands in the doped MOFs\nalso exert strong steric effects to steer the formation of more spacious,\nnon-interpenetrated structures. These findings indicate important\nroles of steric demand and charge balance on ligand doping in MOFs,\nwhich has been well-established in metal ion doping in traditional\ninorganic materials.</p>", "clean_text": "Conclusion\n\nWe have performed systematic studies on doping three sterically demanding Ir/Ru phosphor-based dicarboxylate ligands of varying charges into the known IRMOF-9/-10 structures. The maximum doping levels of these ligands depend on the charge of the ligands. All of the doped systems exhibit a strong tendency of adopting neutral framework structures. This observation is consistent with the general trend of reported MOF structures in the literature: neutral frameworks appear in a much higher frequency than charged ones. Bulky ligands in the doped MOFs also exert strong steric effects to steer the formation of more spacious, non-interpenetrated structures. These findings indicate important roles of steric demand and charge balance on ligand doping in MOFs, which has been well-established in metal ion doping in traditional inorganic materials.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "text", "classification": ["else"], "content": "<p>Crystallographic information files; procedures for ligand synthesis;\nsynthesis and characterization procedures of doped MOF series (NMR,\nTGA, PXRD); X-ray determination; crystal data and structure refinements\nfor MOFs <bold>1</bold>\u2013<bold>3</bold>; spacing-filling models;\nN<sub>2</sub> adsorption isotherms. This material is available free\nof charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p>", "clean_text": "Crystallographic information files; procedures for ligand synthesis; synthesis and characterization procedures of doped MOF series (NMR, TGA, PXRD); X-ray determination; crystal data and structure refinements for MOFs 1-3; spacing-filling models; N2 adsorption isotherms. This material is available free of charge via the Internet at http://pubs.acs.org.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 31, "type": "text", "classification": ["else"], "content": "<p>The authors\ndeclare no competing financial interest.</p><title>References</title>", "clean_text": "The authors declare no competing financial interest.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": 13, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Key Crystallographic Data for MOFs <bold>1</bold>\u2013<bold>3</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">MOF-1</oasis:entry>\n<oasis:entry align=\"center\">MOF-2</oasis:entry>\n<oasis:entry align=\"center\">MOF-3</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>framework\nformula</oasis:entry>\n<oasis:entry>[Zn<sub>4</sub>O(<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>)<sub>3</sub>]</oasis:entry>\n<oasis:entry>[Zn<sub>2</sub>(BPDC)<sub>1.5</sub>(<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>)]</oasis:entry>\n<oasis:entry>[Zn<sub>2</sub>(BPDC)<sub>2</sub>(<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>)<sub>0.5</sub>]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space\ngroup</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">Fm</italic>3<italic toggle=\"yes\">\u0305m</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>222<sub>1</sub>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">C</italic>222<sub>1</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cell\ndimensions (\u00c5)</oasis:entry>\n<oasis:entry>34.0 \u00d7 34.0 \u00d7 34.0</oasis:entry>\n<oasis:entry>18.4 \u00d7\n26.3 \u00d7 42.4</oasis:entry>\n<oasis:entry>18.5 \u00d7 26.9 \u00d7 41.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>interpenetration</oasis:entry>\n<oasis:entry>none</oasis:entry>\n<oasis:entry>2-fold</oasis:entry>\n<oasis:entry>2-fold</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>void\nspace % calcd by PLATON</oasis:entry>\n<oasis:entry>79</oasis:entry>\n<oasis:entry>45</oasis:entry>\n<oasis:entry>60</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>solvent content<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>64DMF\u00b735H<sub>2</sub>O</oasis:entry>\n<oasis:entry>2DMF\u00b77H<sub>2</sub>O</oasis:entry>\n<oasis:entry>9DMF\u00b78H<sub>2</sub>O</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>solvent\nweight loss (%)</oasis:entry>\n<oasis:entry>68</oasis:entry>\n<oasis:entry>19</oasis:entry>\n<oasis:entry>47</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>calculated framework density (g/cm<sup>3</sup>)</oasis:entry>\n<oasis:entry>0.843</oasis:entry>\n<oasis:entry>0.800</oasis:entry>\n<oasis:entry>0.601</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>Solvent contents were determined by a combination of <sup>1</sup>H NMR spectroscopy and TGA. See <xref rid=\"notes-1\">Supporting\nInformation</xref> for detailed analyses.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Key Crystallographic Data for MOFs 1\u20133\n\n|                    | MOF-1                            | MOF-2              | MOF-3                |\n|--------------------|-----------------------------------|---------------------|-----------------------|\n| framework formula  | [Zn<sub>4</sub>O(L<sub>1</sub>)<sub>3</sub>] | [Zn<sub>2</sub>(BPDC)<sub>1.5</sub>(L<sub>2</sub>)] | [Zn<sub>2</sub>(BPDC)<sub>2</sub>(L<sub>3</sub>)<sub>0.5</sub>] |\n| space group        | Fm3\u0305m                             | C222<sub>1</sub>     | C222<sub>1</sub>       |\n| cell dimensions (\u00c5)| 34.0 \u00d7 34.0 \u00d7 34.0                | 18.4 \u00d7 26.3 \u00d7 42.4   | 18.5 \u00d7 26.9 \u00d7 41.8     |\n| interpenetration   | none                              | 2-fold              | 2-fold                |\n| void space % calcd by PLATON | 79                        | 45                  | 60                    |\n| solvent content[^a] | 64DMF\u00b735H<sub>2</sub>O           | 2DMF\u00b77H<sub>2</sub>O | 9DMF\u00b78H<sub>2</sub>O   |\n| solvent weight loss (%) | 68                           | 19                  | 47                    |\n| calculated framework density (g/cm<sup>3</sup>) | 0.843 | 0.800           | 0.601                 |\n\n[^a]: Solvent contents were determined by a combination of 1H NMR spectroscopy and TGA. See Supporting Information for detailed analyses.", "data": [[{"meta": {"name": "MOF-1", "symbol": "", "chemical formula": "[Zn4O(L1)3]"}, "space group": [{"value": "Fm3\u0305m", "condition": ""}], "lattice parameters": [{"value": {"a": "34.0", "b": "34.0", "c": "34.0", "alpha": "", "beta": "", "gamma": ""}, "condition": ""}], "density": [{"value": "0.843", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "MOF-2", "symbol": "", "chemical formula": "[Zn2(BPDC)1.5(L2)]"}, "space group": [{"value": "C2221", "condition": ""}], "lattice parameters": [{"value": {"a": "18.4", "b": "26.3", "c": "42.4", "alpha": "", "beta": "", "gamma": ""}, "condition": ""}], "density": [{"value": "0.800", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "MOF-3", "symbol": "", "chemical formula": "[Zn2(BPDC)2(L3)0.5]"}, "space group": [{"value": "C2221", "condition": ""}], "lattice parameters": [{"value": {"a": "18.5", "b": "26.9", "c": "41.8", "alpha": "", "beta": "", "gamma": ""}, "condition": ""}], "density": [{"value": "0.601", "unit": "g/cm^3", "condition": ""}]}]], "include_properties": ["chemical_formula", "space_group", "lattice_parameters", "density"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Key Crystallographic Data for MOFs 1\u20133\n\n|                    | MOF-1                            | MOF-2              | MOF-3                |\n|--------------------|-----------------------------------|---------------------|-----------------------|\n| framework formula  | [Zn<sub>4</sub>O(L<sub>1</sub>)<sub>3</sub>] | [Zn<sub>2</sub>(BPDC)<sub>1.5</sub>(L<sub>2</sub>)] | [Zn<sub>2</sub>(BPDC)<sub>2</sub>(L<sub>3</sub>)<sub>0.5</sub>] |\n| space group        | Fm3\u0305m                             | C222<sub>1</sub>     | C222<sub>1</sub>       |\n| cell dimensions (\u00c5)| 34.0 \u00d7 34.0 \u00d7 34.0                | 18.4 \u00d7 26.3 \u00d7 42.4   | 18.5 \u00d7 26.9 \u00d7 41.8     |\n| interpenetration   | none                              | 2-fold              | 2-fold                |\n| void space % calcd by PLATON | 79                        | 45                  | 60                    |\n| solvent content[^a] | 64DMF\u00b735H<sub>2</sub>O           | 2DMF\u00b77H<sub>2</sub>O | 9DMF\u00b78H<sub>2</sub>O   |\n| solvent weight loss (%) | 68                           | 19                  | 47                    |\n| calculated framework density (g/cm<sup>3</sup>) | 0.843 | 0.800           | 0.601                 |\n\n[^a]: Solvent contents were determined by a combination of 1H NMR spectroscopy and TGA. See Supporting Information for detailed analyses.\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"MOF-1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"[Zn4O(L1)3]\",\n        },\n        \"space group\": [\n            {\n                \"value\": \"Fm3\u0305m\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"34.0\",\n                    \"b\": \"34.0\",\n                    \"c\": \"34.0\",\n                    \"alpha\": \"\",\n                    \"beta\": \"\",\n                    \"gamma\": \"\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"0.843\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"MOF-2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"[Zn2(BPDC)1.5(L2)]\",\n        },\n        \"space group\": [\n            {\n                \"value\": \"C2221\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"18.4\",\n                    \"b\": \"26.3\",\n                    \"c\": \"42.4\",\n                    \"alpha\": \"\",\n                    \"beta\": \"\",\n                    \"gamma\": \"\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"0.800\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"MOF-3\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"[Zn2(BPDC)2(L3)0.5]\",\n        },\n        \"space group\": [\n            {\n                \"value\": \"C2221\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"18.5\",\n                    \"b\": \"26.9\",\n                    \"c\": \"41.8\",\n                    \"alpha\": \"\",\n                    \"beta\": \"\",\n                    \"gamma\": \"\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"0.601\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 17, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>\n<bold>L</bold> Ligand\nDoping Levels Determined by UV-Vis Spectroscopy</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">ligand and sample number</oasis:entry>\n<oasis:entry align=\"center\">molar ratio\nof Zn(NO<sub>3</sub>)<sub>2</sub>/H<sub>2</sub>\n<bold>L</bold>/H<sub>2</sub>bpdc in the<italic toggle=\"yes\"> </italic>s<italic toggle=\"yes\">y</italic>nthesis</oasis:entry>\n<oasis:entry align=\"center\">phases determined\nfrom PXRD/optical observation/TGA</oasis:entry>\n<oasis:entry align=\"center\">doping level <bold>L</bold>/(<bold>L</bold> + BPDC) (%)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>BPDC-<bold>0</bold>\n</oasis:entry>\n<oasis:entry>2/0/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>1</bold>\n</oasis:entry>\n<oasis:entry>26/1/12</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>4.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>8/1/3</oasis:entry>\n<oasis:entry>IRMOF-9 + IRMOF-10<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry>17</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>4/1/1</oasis:entry>\n<oasis:entry>IRMOF-9 + IRMOF-10</oasis:entry>\n<oasis:entry>39</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>4</bold>\n</oasis:entry>\n<oasis:entry>8/3/1</oasis:entry>\n<oasis:entry>IRMOF-9 + IRMOF-10</oasis:entry>\n<oasis:entry>61</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>1</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>5</bold>\n</oasis:entry>\n<oasis:entry>6/1/0</oasis:entry>\n<oasis:entry>IRMOF-10 (MOF-<bold>1</bold>)</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>1</bold>\n</oasis:entry>\n<oasis:entry>26/1/13</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>20/1/9</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>14/1/6</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>2</bold>\n<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>14</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>4</bold>\n</oasis:entry>\n<oasis:entry>8/1/3</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>26</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>5</bold>\n</oasis:entry>\n<oasis:entry>4/1/1</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>32</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>6</bold>\n</oasis:entry>\n<oasis:entry>8/3/1</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>40 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>7</bold>\n</oasis:entry>\n<oasis:entry>12/5/1</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>40 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>8</bold>\n</oasis:entry>\n<oasis:entry>20/9/1</oasis:entry>\n<oasis:entry>MOF-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>42 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>9</bold>\n</oasis:entry>\n<oasis:entry>4/1/0</oasis:entry>\n<oasis:entry>unknown phase</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>1</bold>\n</oasis:entry>\n<oasis:entry>6.5/4.4/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>n.a.</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>2</bold>\n</oasis:entry>\n<oasis:entry>6.6/3/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>3.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>5.9/1/1</oasis:entry>\n<oasis:entry>IRMOF-9</oasis:entry>\n<oasis:entry>6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>4</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/12</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>3</bold>\n<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>16.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>5</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/18</oasis:entry>\n<oasis:entry>IRMOF-9 + MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>17</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>6</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/22</oasis:entry>\n<oasis:entry>MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>21 \u00b1 3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>-</bold>BPDC-<bold>7</bold>\n</oasis:entry>\n<oasis:entry>17.7/1/33</oasis:entry>\n<oasis:entry>MOF-<bold>3</bold>\n</oasis:entry>\n<oasis:entry>22 \u00b1 3</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>This is a mixture of IRMOF-9 and IRMOF-10 phases, based\non optical observation and TGA.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>These are mixture of IRMOF-9 and MOF-<bold>2/3</bold> phases, based\non PXRD, optical observation and TGA.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. L Ligand Doping Levels Determined by UV-Vis Spectroscopy\n\n| ligand and sample number | molar ratio of Zn(NO3)2/H2 L/H2bpdc in the synthesis | phases determined from PXRD/optical observation/TGA | doping level L/(L + BPDC) (%) |\n|--------------------------|-----------------------------------------------------|----------------------------------------------------|--------------------------------|\n| BPDC-0                   | 2/0/1                                               | IRMOF-9                                            | 0                              |\n| L1-BPDC-1                | 26/1/12                                             | IRMOF-9                                            | 4.5                            |\n| L1-BPDC-2                | 8/1/3                                               | IRMOF-9 + IRMOF-10[^a]                              | 17                             |\n| L1-BPDC-3                | 4/1/1                                               | IRMOF-9 + IRMOF-10[^a]                              | 39                             |\n| L1-BPDC-4                | 8/3/1                                               | IRMOF-9 + IRMOF-10[^a]                              | 61                             |\n| L1-BPDC-5                | 6/1/0                                               | IRMOF-10 (MOF-1)                                    | 100                            |\n| L2-BPDC-1                | 26/1/13                                             | IRMOF-9                                            | 6                              |\n| L2-BPDC-2                | 20/1/9                                              | IRMOF-9                                            | 8                              |\n| L2-BPDC-3                | 14/1/6                                              | IRMOF-9 + MOF-2[^b]                                 | 14                             |\n| L2-BPDC-4                | 8/1/3                                               | IRMOF-9 + MOF-2[^b]                                 | 26                             |\n| L2-BPDC-5                | 4/1/1                                               | IRMOF-9 + MOF-2[^b]                                 | 32                             |\n| L2-BPDC-6                | 8/3/1                                               | MOF-2                                              | 40 \u00b1 5                         |\n| L2-BPDC-7                | 12/5/1                                              | MOF-2                                              | 40 \u00b1 5                         |\n| L2-BPDC-8                | 20/9/1                                              | MOF-2                                              | 42 \u00b1 5                         |\n| L2-BPDC-9                | 4/1/0                                               | unknown phase                                      | 100                            |\n| L3-BPDC-1                | 6.5/4.4/1                                           | IRMOF-9                                            | n.a.                           |\n| L3-BPDC-2                | 6.6/3/1                                             | IRMOF-9                                            | 3.8                            |\n| L3-BPDC-3                | 5.9/1/1                                             | IRMOF-9                                            | 6                              |\n| L3-BPDC-4                | 17.7/1/12                                           | IRMOF-9 + MOF-3[^b]                                 | 16.5                           |\n| L3-BPDC-5                | 17.7/1/18                                           | IRMOF-9 + MOF-3[^b]                                 | 17                             |\n| L3-BPDC-6                | 17.7/1/22                                           | MOF-3                                              | 21 \u00b1 3                         |\n| L3-BPDC-7                | 17.7/1/33                                           | MOF-3                                              | 22 \u00b1 3                         |\n\n[^a]: This is a mixture of IRMOF-9 and IRMOF-10 phases, based on optical observation and TGA.\n[^b]: These are mixture of IRMOF-9 and MOF-2/3 phases, based on PXRD, optical observation and TGA.", "data": [[{"meta": {"name": "BPDC-0", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "molar ratio of Zn(NO3)2/H2 L/H2bpdc in the synthesis", "value": "2/0/1", "unit": "", "condition": ""}, {"property name": "phases determined from PXRD/optical observation/TGA", "value": "IRMOF-9", "unit": "", "condition": ""}, {"property name": "doping level L/(L + BPDC) (%)", "value": "0", "unit": "%", "condition": ""}]}, {"meta": {"name": "L1-BPDC-1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "molar ratio of Zn(NO3)2/H2 L/H2bpdc in the synthesis", "value": "26/1/12", "unit": "", "condition": ""}, {"property name": "phases determined from PXRD/optical observation/TGA", "value": "IRMOF-9", "unit": "", "condition": ""}, {"property name": "doping level L/(L + BPDC) (%)", "value": "4.5", "unit": "%", "condition": ""}]}, 